- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Center for Medicare and Medicaid Innovation Aims to Cut Healthcare Costs
The Obama administration touts it as a key solution to the nation’s runaway healthcare spending: a new national center set up by the 2010 healthcare law to test and implement groundbreaking ways to cut costs while improving patient care.
On Thursday, a little more than 14 months after the center opened, officials will release a report summarizing its progress: 16 recent initiatives, funded with more than $1.7 billion in federal money, that will involve more than 50,000 providers over the next 5 years.
The Center for Medicare and Medicaid Innovation is technically limited to experimenting with payment incentives and methods of delivering care within Medicare and Medicaid, as well as the Children’s Health Insurance Program (CHIP). But its director, Richard Gilfillan, said he will work with providers who also see a large share of private patients, to ensure that the models tested are effective for those populations as well.
Read more at:
Source: The Washington Post
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
